» Authors » Shin-Ichi Tanaka

Shin-Ichi Tanaka

Explore the profile of Shin-Ichi Tanaka including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 22
Citations 241
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Tanaka S, Yamagami K, Sato K, Yasuda H, Niioka H, Wadati H
ACS Omega . 2025 Jan; 9(51):50349-50356. PMID: 39741844
There is great interest in the development of new multifunctional fluorescent-magnetic nanomaterials for use as multimodal diagnostic imaging probes and site-specific drug delivery tools. Metal nanoclusters (NCs) have been reported...
2.
Tanaka S, Wadati H, Sato K, Yasuda H, Niioka H
ACS Omega . 2020 Sep; 5(37):23718-23723. PMID: 32984690
Overexpression of human epidermal growth factor receptor 2 (HER2) is associated with more frequent cancer recurrence and metastasis. Sensitive sensing of HER2 in living breast cancer cells is crucial in...
3.
Minami T, Satoh K, Nogi M, Kudo S, Miyata S, Tanaka S, et al.
Cardiovasc Res . 2015 Nov; 109(1):151-61. PMID: 26598509
Aims: The pleiotropic effects of HMG-CoA reductase inhibitors (statins) independent of cholesterol-lowering effects have attracted much attention. We have recently demonstrated that the pleiotropic effects of statins are partly mediated...
4.
Okanishi T, Akiyama T, Tanaka S, Mayo E, Mitsutake A, Boelman C, et al.
Epilepsia . 2014 Sep; 55(10):1602-10. PMID: 25196064
Objective: Multiple tubers in patients with tuberous sclerosis complex (TSC) often are responsible for drug-resistant epilepsy. The complexity of the epileptic network formed by multiple tubers complicates localization of the...
5.
Elias-Al-Mamun M, Satoh K, Tanaka S, Shimizu T, Nergui S, Miyata S, et al.
Circ J . 2014 Feb; 78(4):967-76. PMID: 24553194
Background:  Pulmonary hypertension (PH) is a fatal disease characterized by pulmonary artery (PA) remodeling, elevated PA pressure and right ventricular (RV) failure. It has been previously demonstrated that treatment with...
6.
Morimura H, Tanaka S, Ishitobi H, Mikami T, Kamachi Y, Kondoh H, et al.
ACS Nano . 2013 Nov; 7(12):10733-40. PMID: 24195575
The plasmon resonant wavelength for a pair of gold nanoparticles, or gold nanodimer, increases inversely with the gap distance between the two nanoparticles. Taking advantage of this property, we performed...
7.
Shimizu T, Fukumoto Y, Tanaka S, Satoh K, Ikeda S, Shimokawa H
Arterioscler Thromb Vasc Biol . 2013 Oct; 33(12):2780-91. PMID: 24135024
Objective: Rho/Rho-kinase (ROCK) pathway in vascular smooth muscle cells (VSMCs) plays an important role in the pathogenesis of cardiovascular diseases, including pulmonary arterial hypertension (PAH). Rho-kinase has 2 isoforms, ROCK1...
8.
Tanaka S, Fukumoto Y, Nochioka K, Minami T, Kudo S, Shiba N, et al.
Arterioscler Thromb Vasc Biol . 2013 May; 33(7):1591-600. PMID: 23640485
Objective: The pleiotropic effects of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) independent of cholesterol-lowering effects are thought to be mediated through inhibition of the Rho/Rho-kinase pathway. However, we have previously demonstrated...
9.
Tanaka S, Fukushima Y, Nakamura I, Tanaki T, Jerkiewicz G
ACS Appl Mater Interfaces . 2013 Mar; 5(8):3340-7. PMID: 23488951
The formation of microporous oxide layers on titanium (Ti) by anodization in sulfuric acid (H2SO4) solution and the influence of prior hydrogen charging on their properties are examined using electrochemical...
10.
Nochioka K, Tanaka S, Miura M, Zhulanqiqige D, Fukumoto Y, Shiba N, et al.
Circ J . 2012 May; 76(8):2023-30. PMID: 22640986
Background: Ezetimibe is an inhibitor of cholesterol absorption in the intestine. We examined whether ezetimibe improves endothelial function, and if so, what mechanisms are involved. Methods And Results: Nineteen healthy...